Healthcare provider profile · identity verified

George L Sabates, M.D.

Internal Medicine · DELRAY BEACH, FL · NPI 1154343317

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	141
Amlodipine Besylate	Amlodipine Besylate	414	121
Levothyroxine Sodium	Levothyroxine Sodium	396	105
Losartan Potassium	Losartan Potassium	370	104
Alprazolam	Alprazolam	336	70
Temazepam	Temazepam	322	42
Lisinopril	Lisinopril	274	77
Simvastatin	Simvastatin	233	65
Metoprolol Succinate	Metoprolol Succinate	215	65
Metformin Hcl	Metformin Hcl	176	53
Rosuvastatin Calcium	Rosuvastatin Calcium	175	53
Pantoprazole Sodium	Pantoprazole Sodium	168	64
Metoprolol Tartrate	Metoprolol Tartrate	161	47
Tamsulosin Hcl	Tamsulosin Hcl	145	51
Eliquis	Apixaban	136	37
Omeprazole	Omeprazole	125	47
Furosemide	Furosemide	123	46
Clopidogrel	Clopidogrel Bisulfate	114	28
Sertraline Hcl	Sertraline Hcl	112	36
Gabapentin	Gabapentin	105	42
Trazodone Hcl	Trazodone Hcl	100	25
Allopurinol	Allopurinol	94	25
Lorazepam	Lorazepam	91	29
Hydrochlorothiazide	Hydrochlorothiazide	82	27
Glipizide	Glipizide	78	18
Fluticasone Propionate	Fluticasone Propionate	74	34
Finasteride	Finasteride	71	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	70	60
Tramadol Hcl	Tramadol Hcl	67	25
Pravastatin Sodium	Pravastatin Sodium	62	21
Carvedilol	Carvedilol	61	21
Spironolactone	Spironolactone	59	22
Escitalopram Oxalate	Escitalopram Oxalate	58	23
Famotidine	Famotidine	58	22
Zolpidem Tartrate	Zolpidem Tartrate	58	11
Lovastatin	Lovastatin	50	17
Glipizide Er	Glipizide	49	13
Clonazepam	Clonazepam	47	12
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Azithromycin	Azithromycin	44	40
Atenolol	Atenolol	42	13
Ondansetron Hcl	Ondansetron Hcl	42	14
Donepezil Hcl	Donepezil Hcl	41	23
Hydralazine Hcl	Hydralazine Hcl	40	13
Quetiapine Fumarate	Quetiapine Fumarate	40	11
Potassium Chloride	Potassium Chloride	39	11
Clonidine Hcl	Clonidine Hcl	36	12
Januvia	Sitagliptin Phosphate	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	26
Diazepam	Diazepam	33	suppressed
Ezetimibe	Ezetimibe	32	12
Glimepiride	Glimepiride	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	11
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	17
Ibuprofen	Ibuprofen	29	11
Meclizine Hcl	Meclizine Hcl	29	16
Meloxicam	Meloxicam	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Primidone	Primidone	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Methylprednisolone	Methylprednisolone	22	19
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Memantine Hcl	Memantine Hcl	21	11
Amoxicillin	Amoxicillin	20	16
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Prednisone	Prednisone	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Levofloxacin	Levofloxacin	17	12
Nystatin	Nystatin	17	11
Ramipril	Ramipril	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	11
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Estradiol	Estradiol	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error